Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00297232
Status:
TERMINATED
Last Update Posted:
2016-07-15
First Post:
2006-02-27
Brief Title:
Natalizumab Tysabri Re-Initiation of Dosing
Sponsor:
Biogen
Organization:
Biogen
Organization Data
Organization:
Biogen
Class:
INDUSTRY
Study ID:
101-MS-321
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biogen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None